| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 10/01/2009 | US20090246202 Human Endokine Alpha and Methods of Use |
| 10/01/2009 | US20090246201 Substances |
| 10/01/2009 | US20090246189 Methods for Promoting Neurite Outgrowth and Survival of Dopaminergic Neurons |
| 10/01/2009 | US20090246186 Agent for improving nervous system cell functions |
| 10/01/2009 | US20090246172 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome |
| 10/01/2009 | US20090246170 Therapeutic Agent For Alzheimer's Disease |
| 10/01/2009 | US20090246147 Delivery Of Antipsychotics Through An Inhalation Route |
| 10/01/2009 | CA2756690A1 Administration of benzodiazepine compositions |
| 10/01/2009 | CA2722618A1 Method of treating degenerative diseases |
| 10/01/2009 | CA2719745A1 Novel p2x7r antagonists and their use |
| 10/01/2009 | CA2719743A1 Substituted cyclohexyldiamines |
| 10/01/2009 | CA2719742A1 Substituted spirocyclic cyclohexane derivatives |
| 10/01/2009 | CA2719740A1 Treatment of brain damage using umbilical cord blood cells |
| 10/01/2009 | CA2719739A1 Hydroxymethylcyclohexylamines |
| 10/01/2009 | CA2719736A1 Spiro(5.5)undecane derivatives |
| 10/01/2009 | CA2719735A1 Substituted 4-aminocyclohexane derivatives |
| 10/01/2009 | CA2719624A1 Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-1,4-benzodioxin-2-yl) methyl-sulfamide |
| 10/01/2009 | CA2719582A1 Neurodegenerative disorders |
| 10/01/2009 | CA2719577A1 Use of ferritin to treat iron deficiency disorders |
| 10/01/2009 | CA2719412A1 Pyrido[3,4-b]indoles and methods of use |
| 10/01/2009 | CA2719402A1 Process for preparation of benzo-fused heteroaryl derivatives |
| 10/01/2009 | CA2719226A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 10/01/2009 | CA2719164A1 Process for the preparation of donepezil hydrochloride |
| 10/01/2009 | CA2718790A1 Bridged heterocyclic compounds and methods of use |
| 10/01/2009 | CA2718727A1 Heterocyclic compound |
| 10/01/2009 | CA2718411A1 Use and composition for treating dementia |
| 10/01/2009 | CA2718209A1 (hetero)aryl cyclohexane derivatives |
| 10/01/2009 | CA2717384A1 Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism |
| 10/01/2009 | CA2717099A1 Compositions and methods for transmucosal delivery of lofexidin |
| 10/01/2009 | CA2716961A1 Azetidine-derived compounds, preparation method therefor and therapeutic use of same |
| 10/01/2009 | CA2715151A1 Monocyclic cgrp receptor antagonists |
| 10/01/2009 | CA2712468A1 Aminopiperidinyl derivatives and uses thereof |
| 09/30/2009 | EP2105497A1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom |
| 09/30/2009 | EP2105441A1 Alanyl aminopeptidase and dipeptidylpeptidase IV dual inhibitors for the treatment of immunological, inflammatory, neuronal and other illnesses |
| 09/30/2009 | EP2105164A1 Novel P2X7R antagonists and their use |
| 09/30/2009 | EP2105136A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105135A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105133A1 Intragastric floating-type levodopa sustained-release preparation |
| 09/30/2009 | EP2104677A1 Spiropiperidine glycinamide derivatives |
| 09/30/2009 | EP2104504A2 Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative |
| 09/30/2009 | EP2104503A1 Morpholine dopamine agonists for the treatment of pain |
| 09/30/2009 | EP2104494A1 Method for reducing inflammatory responses and inflammation |
| 09/30/2009 | EP2041082B1 Pyrrolidine derivatives having activity at the glyt1 transporter |
| 09/30/2009 | EP1963355B1 New cholest-4-en-3-one oxime derivatives, pharmaceutical compositions comprising them, and preparation process |
| 09/30/2009 | EP1962849B1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders |
| 09/30/2009 | EP1739186B1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor |
| 09/30/2009 | EP1611129B1 Cyclic sulfamides for inhibition of gamma-secretase |
| 09/30/2009 | EP1553089B1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient |
| 09/30/2009 | EP1471892B1 Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine |
| 09/30/2009 | EP1453525B1 Selective targeting of apoptotic cells |
| 09/30/2009 | EP1435944B1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 09/30/2009 | EP1342085B1 Non-apoptotic forms of cell death and methods of modulation |
| 09/30/2009 | EP1295604B1 Preventives and remedies for diseases in association with demyelination |
| 09/30/2009 | CN101544644A Preparation method of mianserin hydrochloride |
| 09/30/2009 | CN101544600A Method for separating and preparing ricinine |
| 09/30/2009 | CN101544599A Crystal of 1,2-dihydropyridine compound |
| 09/30/2009 | CN101544592A N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| 09/30/2009 | CN101544579A Use and preparation method of 4-(-2-acetoxybenzoyl)aminobutyric acid and ester derivative thereof |
| 09/30/2009 | CN101543624A Purpose of Chilobrachys jingzhao toxin extract-jingzhao toxin-V(JZTX-V) in preparation of drug-breaking medicament |
| 09/30/2009 | CN101543611A Traditional Chinese medicine for treating hysteria |
| 09/30/2009 | CN101543596A Traditional Chinese medicine composition for curing sciatica and preparation method thereof |
| 09/30/2009 | CN101543588A Medicine composition for treating facioplegia and preparation method thereof |
| 09/30/2009 | CN101543587A Chinese herbal compound for treating multiple convulsion and pharmaceutical composition using same |
| 09/30/2009 | CN101543580A Traditional Chinese medicine micro pills for treating sciatica and preparation method thereof |
| 09/30/2009 | CN101543576A Medicine composition for preventing and curing senile dementia and preparation method thereof |
| 09/30/2009 | CN101543571A Rhizoma paridis total aglycone sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543570A Smilax glabra total aglycone oral pharmaceutical preparation as well as preparation method and application thereof |
| 09/30/2009 | CN101543568A Yam total sapogenin sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543559A Medicine composition for preventing senile dementia |
| 09/30/2009 | CN101543558A Medicine composition for treating facioplegia and preparation method thereof |
| 09/30/2009 | CN101543557A Medicine composition for expelling wind, clearing away cold, clearing and activating the channels and collaterals and preparation method thereof |
| 09/30/2009 | CN101543546A Antioxidative substance and composition and use thereof |
| 09/30/2009 | CN101543544A Chinese medicinal preparation for treating nervous headache |
| 09/30/2009 | CN101543542A Traditional Chinese medicine preparation for treating insomnia |
| 09/30/2009 | CN101543522A Facial palsy healing paste |
| 09/30/2009 | CN101543518A Ginseng stem leaf total sapogenin oral pharmaceutical preparation as well as preparation method and application thereof |
| 09/30/2009 | CN101543517A Folium ginkgo total flavonoid aglycone sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543507A Immunostimulatory nucleic acids |
| 09/30/2009 | CN101543505A Medicine for preventing and treating Alzheimer's disease and preparing method thereof |
| 09/30/2009 | CN101543500A Dhea composition and method |
| 09/30/2009 | CN101543497A Methods of treating patients suffering from movement disorders |
| 09/30/2009 | CN101543496A Novel pharmaceutical composition of medicament promoting nerve remodeling and preparation method thereof |
| 09/30/2009 | CN101543489A Compounds as liver X receptor modifier |
| 09/30/2009 | CN101543486A Application of tetrahydrocurcumin in preparing antidepressant and method for preparing solid dispersion of tetrahydrocurcumin |
| 09/30/2009 | CN101543485A Application of 28 alkanol as anti-Parkinson's disease substance in medicaments and health care products |
| 09/30/2009 | CN100544726C DHEA composition and method |
| 09/30/2009 | CN100544715C Composition of free-B-ring flavonoids and flavans as a therapeutic agent |
| 09/29/2009 | US7596455 Crystallization of IGF-1 |
| 09/29/2009 | US7595399 Tyrosine derivatives |
| 09/29/2009 | US7595344 Sulphones which modulate the action of gamma secretase |
| 09/29/2009 | US7595336 Isatine derivatives with neurotrophic activity |
| 09/29/2009 | US7595332 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
| 09/29/2009 | US7595331 N-and O-substituted 4-[2-(diphenylmethoxy)-ethyl]-1-[(phenyl)methyl]piperidine analogs and methods of treating CNS disorders therewith |
| 09/29/2009 | US7595329 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; gastroesophageal reflux disease, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability |
| 09/29/2009 | US7595321 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(2-cyanoethyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 09/29/2009 | US7595319 Compounds having selective inhibiting effect at GSK3 |
| 09/29/2009 | US7595317 Antiarthritic agents; rheumatoid and osteoarthritis; corneal, epidermal, or gastric ulceration; tumor metastasis or invasion; periodontal disease; and bone disease; 4-[(2-methyl-4-quinolinyl)methoxy]-N-(1,3,5-trioxo-2,4-diazaspiro[5.5]undec-7-yl)benzamide trifluoroacetate, for example |
| 09/29/2009 | US7595316 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
| 09/29/2009 | US7595314 Such as (2-morpholin-4-yl-5-nitro-phenyl)-[4-(5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-methanone; for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
| 09/29/2009 | CA2493370C Crystal forms of olanzapine and processes for their preparation |